New Treatment GL for Advanced HCC to Be Issued in October, Will Recommend Nexavar for 1st-Line Treatment

The Japan Society of Hepatology (JSH) has drafted “clinical practice guidelines for hepatocellular carcinoma 2017”, which it plans to issue in mid-October. This is the first revision of the guidelines in four years. They will strongly recommend Bayer Yakuhin’s Nexavar...read more